Live Breaking News & Updates on Erck kgaa

Stay informed with the latest breaking news from Erck kgaa on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Erck kgaa and stay connected to the pulse of your community

Biopharmaceutical Processing Equipment Consumables Market

“Biopharmaceutical Processing Equipment Consumables Market” from 2024-2034 with covered segments (Biopharmaceutical Processing Equipment Consumables...

Eppendorf , Nordrhein-westfalen , Germany , France , Spain , Canada , Italy , United-kingdom , Russia , Argentina , Australia , Mexico

Thema: Pediatric Patients

Aktuelle Presseaussendungen zum Thema "Pediatric Patients" von Takeda Pharma Vertrieb GmbH & Co. KG und anderen

Philips , European-hospitals , Uot-pediatric-patients-quot- , Akeda-pharma-vertrieb-gmbh-amp-co-kg , Akeda , Hilips-disney , Erck-kgaa , Resseaussendung , Ressemitteilung , Pa , Ts

Germany's Merck says semiconductor M&A deals face political hurdles, ET Telecom

CEO Belen Garijo said in August that any deal could take a while and that acquisitions to strengthen Merck's Life Science unit, a supplier of gear and substances for the pharmaceutical industry, were a priority. Deals in drug development or semiconductor chemicals remained on the cards, the CEO said at the time.

Belen-garijo , Life-science , Merck , Erck-kgaa , Elen-garijo , Ercks-life-science , Emiconductor ,

Merck KGaA Puts Up €160M for Drug to Rival DNA Damage Cancer Meds From AstraZeneca, Gilead

A Hengrui drug that interferes with a cancer cell’s DNA damage response is heading to Merck KGaA for €160 million up front and up to €1.4 billion tied to milestones. The deal also gives the German company an option to license a Hengrui antibody drug conjugate.

China , Germany , German , Merck-kgaa-hengrui , Daiichi-sankyo , Merck-kga , Astrazeneca , Jiangsu-hengrui-pharmaceuticals , Gilead-sciences , Merck-kgaa , Jiangsu-hengrui , China-based-hengrui

EMD Serono Presents New MAVENCLAD® (Cladribine) Tablets Data Highlighting Sustained Reduction in NfLs and Benefit of Early Initiation

ROCKLAND, Mass., October 10, 2023--EMD Serono, the Healthcare business sector of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, today announced the presentation of new analyses from the MAVENCLAD® (cladribine) tablets MAGNIFY-MS study, which demonstrated that patients with relapsing multiple sclerosis (RMS) experienced sustained reduction in serum neurofilament light chain (NfL), indicating that MAVENCLAD reduced neuronal injury over two years. Additional data include two real-world evi

Germany , United-kingdom , Italy , Australia , Switzerland , United-states , Milan , Lombardia , Massachusetts , Canada , Rockland , Ontario

EMD Serono Launches New Collaboration with United Nations-Guided Global Initiative on Ageing to Support Caregivers

ROCKLAND, Mass., October 05, 2023--EMD Serono, the Healthcare business of Merck KGaA, Darmstadt, Germany in the US and Canada, today announced a new collaboration with the United Nations-Guided Global Initiative on Ageing (GIA) to provide a training course on critical skills for family caregivers. The course, consisting of 5 modules, provides professional instruction and guidance on essential topics in caregiving such as using medical equipment, creating safe environments and overcoming communic

Massachusetts , United-states , Spain , Canada , Germany , Rockland , Ontario , Spanish , Americans , Peter-guenter , Luis-gallegos , Serono-inc

Merck KGaA Expands in AI-Driven R&D With Two Drug Discovery Deals

Specific targets were not disclosed, but Merck KGaA is betting the artificial intelligence technologies of Exscientia and BenevolentAI will discover into new drugs for cancer, neurology, and immunology.

London , City-of , United-kingdom , Germany , Merck-kga , Astrazeneca , Melinda-gates-foundation , Bristol-myers-squibb , Merck-kgaa , United-kingdom-based , Melinda-gates

Global Cell Culture Media Market, Forecast & Opportunities, 2028

Bharat Book Bureau Provides the Trending Market Research Report on Cell Culture Media Market by Payment Method, Vertical - Global Forecast to…

South-korea , United-states , France , India , Japan , Canada , Bharat , America , Asia-pacific , Caisson-laboratories-inc , Product-development-innovation , Technologies-inc

Investegate |Merck KGaA Announcements | Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Investegate announcements from Merck KGaA, Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Rate-fix , Investegate-announcements , Nvestegate-company-announcements , Erck-kgaa , Qs , Qs-and-eqs , Qs- ,

Investegate |Merck KGaA Announcements | Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Investegate announcements from Merck KGaA, Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Rate-fix , Investegate-announcements , Nvestegate-company-announcements , Erck-kgaa , Qs , Qs-and-eqs , Qs- ,